Article info
PDFPapers
Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study
- Correspondence to:
Dr K W Rammohan, Department of Neurology Ohio State University, 449 Means Hall, 1654 Upham Drive, Columbus, Ohio 43210 Columbus, Ohio, USA;
rammohan.2{at}osu.edu
Citation
Efficacy and safety of modafinil (Provigil®) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study
Publication history
- Received November 15, 2000
- Revised August 15, 2001
- Accepted August 17, 2001
- First published February 1, 2002.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 Journal of Neurology Neurosurgery and Psychiatry